Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
| Revenue (TTM) | $8.51B |
| Gross Profit (TTM) | $5.92B |
| EBITDA | $2.52B |
| Operating Margin | 18.00% |
| Return on Equity | 6.41% |
| Return on Assets | 3.88% |
| Revenue/Share (TTM) | $43.50 |
| Book Value | $66.23 |
| Price-to-Book | 1.37 |
| Price-to-Sales (TTM) | 2.04 |
| EV/Revenue | 2.868 |
| EV/EBITDA | 10.47 |
| Quarterly Earnings Growth (YoY) | 33.80% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $190.74M |
| Float | $190.13M |
| % Insiders | 0.16% |
| % Institutions | 111.42% |
Volatility is currently expanding
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Gary Campbell promoted to President, Americas Brian Hatcher promoted to President, Recon, S.E.T., CMFT, Neuro and Biosurgery Bradley Kessler promoted to President, Americas – Robotics, Technology and Data WARSAW, Ind.
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZBH and any ticker you trade — then tracks every position and per-strategy win rate.
